{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:08:39Z","timestamp":1792242519358,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T00:00:00Z","timestamp":1382140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12015-013-9478-8","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T08:09:00Z","timestamp":1382083740000},"page":"79-85","source":"Crossref","is-referenced-by-count":24,"title":["The Potential Role of Genetically-Modified Pig Mesenchymal Stromal Cells in Xenotransplantation"],"prefix":"10.1007","volume":"10","author":[{"given":"Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed B.","family":"Ezzelarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ayares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K. C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,19]]},"reference":[{"key":"9478_CR1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., & Frolova, G. P. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6, 230\u2013247.","journal-title":"Transplantation"},{"key":"9478_CR2","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/TP.0b013e3181a28533","volume":"87","author":"V Sordi","year":"2009","unstructured":"Sordi, V. (2009). Mesenchymal stem cell homing capacity. Transplantation, 87, S42\u2013S45.","journal-title":"Transplantation"},{"key":"9478_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315\u2013317.","journal-title":"Cytotherapy"},{"key":"9478_CR4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/0022034512460404","volume":"91","author":"L Wang","year":"2012","unstructured":"Wang, L., Zhao, Y., & Shi, S. (2012). Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration. Journal of Dental Research, 91, 1003\u20131010.","journal-title":"Journal of Dental Research"},{"key":"9478_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","volume":"5","author":"S Wang","year":"2012","unstructured":"Wang, S., Qu, X., & Zhao, R. C. (2012). Clinical applications of mesenchymal stem cells. Journal of Hematology and Oncology, 5, 19.","journal-title":"Journal of Hematology and Oncology"},{"key":"9478_CR6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet, 371, 1579\u20131586.","journal-title":"Lancet"},{"key":"9478_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","volume":"60","author":"K Blanc Le","year":"2004","unstructured":"Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., et al. (2004). Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scandinavian Journal of Immunology, 60, 307\u2013315.","journal-title":"Scandinavian Journal of Immunology"},{"key":"9478_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders, M. E., Fijter, J. W., Roelofs, H., Bajema, I. M., Vries, D. K., Schaapherder, A. F., et al. (2013). Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Translational Medicine, 2, 107\u2013111.","journal-title":"Stem Cells Translational Medicine"},{"key":"9478_CR9","unstructured":"Mesenchymal stem cell transplantation in the treatment of chronic allograft nephropathy. (Under investigation, ClinicalTrials.gov Identifier: NCT00659620)"},{"key":"9478_CR10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico, N., Casiraghi, F., Introna, M., Gotti, E., Todeschini, M., Cavinato, R. A., et al. (2011). Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clinical Journal of the American Society of Nephrology, 6, 412\u2013422.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"9478_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/xen.12000","volume":"19","author":"J Li","year":"2012","unstructured":"Li, J., Ezzelarab, M. B., & Cooper, D. K. (2012). Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation, 19, 273\u2013285.","journal-title":"Xenotransplantation"},{"key":"9478_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-3089.2009.00567.x","volume":"17","author":"M Ezzelarab","year":"2010","unstructured":"Ezzelarab, M., Ayares, D., & Cooper, D. K. (2010). The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantation. Xenotransplantation, 17, 3\u20135.","journal-title":"Xenotransplantation"},{"key":"9478_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-3089.2011.00635.x","volume":"18","author":"M Ezzelarab","year":"2011","unstructured":"Ezzelarab, M., Ezzelarab, C., Wilhite, T., Kumar, G., Hara, H., Ayares, D., et al. (2011). Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses. Xenotransplantation, 18, 183\u2013195.","journal-title":"Xenotransplantation"},{"key":"9478_CR14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3109\/14653249.2011.651529","volume":"14","author":"G Kumar","year":"2012","unstructured":"Kumar, G., Hara, H., Long, C., Shaikh, H., Ayares, D., Cooper, D. K., et al. (2012). Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Cytotherapy, 14, 494\u2013504.","journal-title":"Cytotherapy"},{"key":"9478_CR15","doi-asserted-by":"crossref","unstructured":"Li, J., Andreyeva, O., Chen, M., Marcoa, M., Iwasea, H., Long, C., et al. (2013). Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells. Cellular Immunology (in press).","DOI":"10.1016\/j.cellimm.2013.08.004"},{"key":"9478_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1399-3089.2012.00708.x","volume":"19","author":"DK Cooper","year":"2012","unstructured":"Cooper, D. K., Ekser, B., Burlak, C., Ezzelarab, M., Hara, H., Paris, L., et al. (2012). Clinical lung xenotransplantation\u2013what donor genetic modifications may be necessary? Xenotransplantation, 19, 144\u2013158.","journal-title":"Xenotransplantation"},{"key":"9478_CR17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(11)61091-X","volume":"379","author":"B Ekser","year":"2012","unstructured":"Ekser, B., Ezzelarab, M., Hara, H., van der Windt, D. J., Wijkstrom, M., Bottino, R., et al. (2012). Clinical xenotransplantation: the next medical revolution? Lancet, 379, 672\u2013683.","journal-title":"Lancet"},{"key":"9478_CR18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1432-2277.2008.00736.x","volume":"21","author":"H Hara","year":"2008","unstructured":"Hara, H., Long, C., Lin, Y. J., Tai, H. C., Ezzelarab, M., Ayares, D., et al. (2008). In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transplant International, 21, 1163\u20131174.","journal-title":"Transplant International"},{"key":"9478_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.1078942","volume":"299","author":"CJ Phelps","year":"2003","unstructured":"Phelps, C. J., Koike, C., Vaught, T. D., Boone, J., Wells, K. D., Chen, S. H., et al. (2003). Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299, 411\u2013414.","journal-title":"Science"},{"key":"9478_CR20","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2337\/db09-0749","volume":"58","author":"TM Brusko","year":"2009","unstructured":"Brusko, T. M. (2009). Mesenchymal stem cells: a potential border patrol for transplanted islets? Diabetes, 58, 1728\u20131729.","journal-title":"Diabetes"},{"key":"9478_CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","volume":"32","author":"MG Solari","year":"2009","unstructured":"Solari, M. G., Srinivasan, S., Boumaza, I., Unadkat, J., Harb, G., Garcia-Ocana, A., et al. (2009). Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. Journal of Autoimmunity, 32, 116\u2013124.","journal-title":"Journal of Autoimmunity"},{"key":"9478_CR22","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","volume":"69","author":"GV Rosland","year":"2009","unstructured":"Rosland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., et al. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Research, 69, 5331\u20135339.","journal-title":"Cancer Research"},{"key":"9478_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jcp.20376","volume":"205","author":"V Vacanti","year":"2005","unstructured":"Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J. M., & Lee, T. (2005). Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. Journal of Cellular Physiology, 205, 194\u2013201.","journal-title":"Journal of Cellular Physiology"},{"key":"9478_CR24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biocel.2003.11.001","volume":"36","author":"FP Barry","year":"2004","unstructured":"Barry, F. P., & Murphy, J. M. (2004). Mesenchymal stem cells: clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology, 36, 568\u2013584.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"9478_CR25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8, 726\u2013736.","journal-title":"Nature Reviews Immunology"},{"key":"9478_CR26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI12150","volume":"107","author":"KA Jackson","year":"2001","unstructured":"Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107, 1395\u20131402.","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-013-9478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-013-9478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-013-9478-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:45:04Z","timestamp":1559439904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-013-9478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9478"],"URL":"https:\/\/doi.org\/10.1007\/s12015-013-9478-8","relation":{},"ISSN":["1550-8943","1558-6804"],"issn-type":[{"value":"1550-8943","type":"print"},{"value":"1558-6804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,19]]}}}